Wunmi Bakare, founder of Sickle Cell Prodigy, will be presenting at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting in Boston next week. She will be speaking in the session: “Shared decisions, shared success: engaging stakeholders in CGT translational research.” Topic: Pivotal decision points for participants with Sickle Cell Disease